Collectively, this data suggests that both AZD8055 and NVP-BEZ235 mono-therapy decreased tumor growth in LKB1−/−NIC mice, however the inhibition of mTOR by AZD8055 was significantly more effective at preventing tumor growth compared with NVP-BEZ235 treatment alone. The gene discussed is MTOR; the disease is neoplasm.